The global Allergy Treatment Market is anticipated to achieve a CAGR of 6.9% from 2022 to 2032, resulting in an extravagant growth outlook for the industry throughout the evaluation period. The market is expected to be worth US$ 38.9 billion by 2032, up from an estimated US$ 20.20 billion in 2022. The market is expanding as a …
Category Archives: Healthcare Trends
Injectable Drugs Market to Achieve 5.8% CAGR, Anticipated Valuation of US$937.0 Billion by 2032 | According to FMI
According to Future Market Insights’ analysis, the Injectable Drugs Market is set to grow at a 5.8% CAGR over the assessment period. As per the report, the market is projected to be valued at US$ 937.0 Bn by the end of 2032. Advancements in technologies that involve optimization of the devices used for clinical conditions, be it chronic or acute, …
Glucose Monitoring Devices Market Surpasses US$ 118.1 Billion Valuation by 2033, to Grow at a Robust CAGR of 16.9% | FMI Insights
According to Future Market Insights’ most recent industry report, the global Glucose Monitoring Devices Market was valued at roughly US$ 21.3 Billion in 2022 and is expected to rise at a CAGR close to 16.9% over the forecast period, reaching an estimated worth of US$ 118.1 Billion in 2033. Over the past 20 years, diabetes has escalated to a severe health concern with …
Prosthetics and Orthotics Market: Exceeding US$ 12.2 Billion at a Steady 6% CAGR between 2023 and 2033 | According to Future Market Insights
According to Future Market Insights’ most recent report, sales of the Prosthetics and Orthotics Market worldwide were estimated to reach US$ 6.5 billion in 2022. By 2033, the market is anticipated to surpass US$ 12 billion from 2023 to 2033. From 2023 to 2033, the market for orthotics is predicted to develop at a CAGR of …
Intraoral Scanners Market Projected to Achieve Remarkable 7.6% CAGR, Envisioned to Reach a Valuation of US$ 1,345.0 Million by 2032
The global Intraoral Scanners Market size is predicted to be worth US$ 644.8 million by the end of 2022 and to grow at a CAGR of 7.6% to be worth US$ 1,345.0 million by the end of 2032. According to a recent analysis by Future Market Insights, intraoral scanners will lead the global intraoral scanners market with …
Wheelchairs Market Expected to Reach a Valuation of US$ 7.9 Billion by 2032, with a Steady Compound Annual Growth Rate of 3.2%
The global Wheelchairs Market is predicted to be worth US$ 5.7 billion by the end of 2022 and to grow at a CAGR of 3.2% to be worth US$ 7.9 billion by the end of 2032. According to a recent analysis by Future Market Insights, manual wheelchairs will account for around 70.5% of the global …
Anticipated Growth: Dermal Fillers Market Projected to Expand with a 7.5% CAGR from 2023 to 2033
The Dermal Fillers Market is anticipated to grow at a 7.5% CAGR between 2023 and 2033. They are employed to rejuvenate various facial regions linked to various functions. The market is expanding as a result of the rising demand for facelifts and face-line corrections in various emerging nations. Elevate Your Understanding with PDF Sample Downloads. …
Middle East Veterinary Vaccines Market Set to Surpass US$533.4 Million by 2031, With a Cumulative CAGR of approximately 4.8%
According to a recent study by Future Market Insights (FMI), the Middle East Veterinary Vaccines Market is expected to witness moderate growth during the forecast period. The market is expected to grow from US$ 350.8 Mn in 2022 to over US$ 533.4 Mn by 2031. This reflects a cumulative CAGR of around 4.8% over the forecast period …
Branded Generics Market Poised to Surpass US$747 Million Milestone with Impressive 8.6% CAGR
The Branded Generics Market is anticipated to be valued at US$ 327.8 million in 2023. By 2033, the market for branded generics is anticipated to reach US$ 747.2 million, growing at a CAGR of 8.6%. The rapid expansion of the branded generics market can be ascribed to the rising number of blockbuster or branded medicines whose patents …
Biopharmaceutical Contract Manufacturing Market Poised to Achieve Remarkable Growth, Projected at a CAGR of 10.5% Enroute to a Valuation of US$ 18.7 Billion by 2029
Global Biopharmaceutical Contract Manufacturing Market was estimated to be worth roughly US$ 9.3 Billion in 2022 and is expected to grow at a CAGR of 10.5% to reach US$ 18.7 billion by 2029. A few benefits provided by biopharmaceutical manufacturing businesses include access to pricey technologies, a shorter overall time to market investment for new pharmaceuticals, and increased flexibility. Several multinational corporations …